I Oppose HB 3603. Vaccines Are Not Safe for Everyone. One Such Person
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
ICD-10-CM Expert for SNF, IRF, and LTCH the Complete Official Code Set Codes Valid from October 1, 2018 Through September 30, 2019
EXPERT 2019 ICD-10-CM Expert for SNF, IRF, and LTCH The complete official code set Codes valid from October 1, 2018 through September 30, 2019 Power up your coding optum360coding.com ITSN_ITSN19_CVR.indd 1 12/4/17 2:54 PM Contents Preface ................................................................................ iii ICD-10-CM Index to Diseases and Injuries .......................... 1 ICD-10-CM Official Preface ........................................................................iii Characteristics of ICD-10-CM ....................................................................iii ICD-10-CM Neoplasm Table ............................................ 331 What’s New for 2019 .......................................................... iv ICD-10-CM Table of Drugs and Chemicals ...................... 349 Official Updates ............................................................................................iv Proprietary Updates ...................................................................................vii ICD-10-CM Index to External Causes ............................... 397 Introduction ....................................................................... ix ICD-10-CM Tabular List of Diseases and Injuries ............ 433 History of ICD-10-CM .................................................................................ix Chapter 1. Certain Infectious and Parasitic Diseases (A00-B99) .........................................................................433 How to Use ICD-10-CM Expert for Skilled Nursing Chapter -
Café Au Lait Spots As a Marker of Neuropaediatric Diseases
Mini Review Open Access J Neurol Neurosurg Volume 3 Issue 5 - May 2017 DOI: 10.19080/OAJNN.2017.03.555622 Copyright © All rights are reserved by Francisco Carratalá-Marco Café Au Lait Spots as a Marker of Neuropaediatric Diseases Francisco Carratalá-Marco1*, Rosa María Ruiz-Miralles2, Patricia Andreo-Lillo1, Julia Dolores Miralles-Botella3, Lorena Pastor-Ferrándiz1 and Mercedes Juste-Ruiz2 1Neuropaediatric Unit, University Hospital of San Juan de Alicante, Spain 2Paediatric Department, University Hospital of San Juan de Alicante, Spain 3Dermatology Department, University Hospital of San Juan de Alicante, Spain Submission: March 22, 2017; Published: May 10, 2017 *Corresponding author: Francisco Carratalá-Marco, Neuropaediatric Unit, University Hospital of San Juan de Alicante, Spain, Tel: ; Email: Abstract Introduction: want to know in which The measure,Café au lait the spots presence (CALS) of isolated are shown CALS in representsthe normal a population risk factor forwithout neurological pathological disease. significance, although they could also be criteria for some neurologic syndromes. Unspecific association with general neurologic illnesses has been less frequently described. We Patients and methods: We set up an observational transversal study of cases, patients admitted for neuropaediatric reasons (NPP; n=49) excluding all the patients suffering from neurologic illnesses associated to CALS, and controls, a hospital simultaneously admitted pediatric population for non-neurologic causes (CP; n=101) since October 2012 to January 2013. The data were collected from the clinical reports at admission, and then analyzed by SPSS 22.0 statistical package, and the Stat Calc module of EpiInfo 7.0, following the ethics current rules of the institution for observational studies. -
Controversial CFS Researcher Arrested and Jailed - Scienceinsider
Controversial CFS Researcher Arrested and Jailed - ScienceInsider http://news.sciencemag.org/scienceinsider/2011/11/controversial-cfs-researcher-arr.html?ref=em... AAAS.ORG FEEDBACK HELP LIBRARIANS Daily News Enter Search Term ADVANCED ALERTS ACCESS RIGHTS MY ACCOUNT SIGN IN News Home ScienceNOW ScienceInsider Premium Content from Science About Science News Home > News > ScienceInsider > November 2011 > Controversial CFS Researcher Arrested and Jailed Controversial CFS Researcher Arrested and Jailed by Jon Cohen on 19 November 2011, 6:46 PM | 16 Comments Email Print | 0 More PREVIOUS ARTICLE NEXT ARTICLE 1 of 5 12/1/11 10:06 AM Controversial CFS Researcher Arrested and Jailed - ScienceInsider http://news.sciencemag.org/scienceinsider/2011/11/controversial-cfs-researcher-arr.html?ref=em... Judy Mikovits, who has been in the spotlight for the past 2 years after Science published a controversial report by her group that tied a novel mouse retrovirus to chronic fatigue syndrome (CFS), is now behind bars. Sheriffs in Ventura County, California, arrested Mikovits yesterday on felony charges that she is a fugitive from justice. She is being held at the Todd Road Jail in Santa Paula without bail. But ScienceInsider could obtain only sketchy details about the specific charges against her. The Ventura County sheriff's office told ScienceInsider that it had no available details about the charges and was acting upon a warrant issued by Washoe County in Nevada. A spokesperson for the Washoe County Sheriff's Office told ScienceInsider that it did not issue the warrant, nor did the Reno or Sparks police department. He said it could be from one of several federal agencies in Washoe County. -
Ketogenic Diet and Immunotherapy in Cancer and Neurological Diseases
American Journal of Immunology Editorials Ketogenic Diet and Immunotherapy in Cancer and Neurological Diseases. 4th International Congress on Integrative Medicine, 1, 2 April 2017, Fulda, Germany 1Thomas Peter and 2Marco Ruggiero 1Therapy Center Anuvindati, Bensheim, Germany 2Silver Spring Sagl, Arzo-Mendrisio, Switzerland Article history Abstract: In this Meeting Report, we review proceedings and comment Received: 23-08-2017 on talks given at the 4 th International Congress on Integrative Medicine Revised: 23-08-2017 Accepted: 25-09-2017 held on April 1 and 2, 2017, in Fulda, Germany. The Theme this year was “Ketogenic Diet and Immunotherapy in Cancer and Neurological Diseases.” Corresponding Author: Speakers came from Europe and the United States and the Congress was Marco Ruggiero attended by more than 100 interested parties from all over the world. Silver Spring Sagl. Via Raimondo Rossi 24, Arzo- Mendrisio 6864, Switzerland Keywords: Ketogenic Diet, Immunotherapy, Integrative Medicine, Email: [email protected] Cancer, Autism, Lyme Disease Introduction a talk entitled "Exploiting cancer metabolism with th ketosis and hyperbaric oxygen". Dr. Poff lectured on the The 4 International Congress on Integrative synergism between nutritional ketosis and hyperbaric Medicine, was held on 1 and 2 April, 2017, in Fulda, oxygen in reducing tumor burden in experimental Germany. The theme of this Congress was "Ketogenic animals and offered insights on the mechanism of action Diet and Immunotherapy in Cancer and Neurological of ketone bodies in a variety of conditions from seizures Diseases" (Ketogene Ernährung und Immuntherapie bei to cancer proliferation. The role of exogenous ketone Krebs und Neurologischen Erkrankungen). bodies in counteracting cancer cell proliferation even in The Congress brought together researchers from all the absence of carbohydrate restriction was also over the world to share their views and research on the discussed. -
ICD-10-CM TABULAR LIST of DISEASES and INJURIES 2018 Addenda No Change Chapter 1 No Change Certain Infectious and Parasitic Diseases (A00-B99)
ICD-10-CM TABULAR LIST of DISEASES and INJURIES 2018 Addenda No Change Chapter 1 No Change Certain infectious and parasitic diseases (A00-B99) No Change Intestinal infectious diseases (A00-A09) No Change A04 Other bacterial intestinal infections No Change A04.7 Enterocolitis due to Clostridium difficile Add A04.71 Enterocolitis due to Clostridium difficile, recurrent Add A04.72 Enterocolitis due to Clostridium difficile, not specified as recurrent No Change A05 Other bacterial foodborne intoxications, not elsewhere classified No Change Excludes1: Revise from Clostridium difficile foodborne intoxication and infection (A04.7) Revise to Clostridium difficile foodborne intoxication and infection (A04.7-) No Change Helminthiases (B65-B83) No Change B81 Other intestinal helminthiases, not elsewhere classified No Change Excludes1: Revise from angiostrongyliasis due to Parastrongylus cantonensis (B83.2) Revise to angiostrongyliasis due to: Add Angiostrongylus cantonensis (B83.2) Add Parastrongylus cantonensis (B83.2) No Change B81.3 Intestinal angiostrongyliasis Revise from Angiostrongyliasis due to Parastrongylus costaricensis Revise to Angiostrongyliasis due to: Add Angiostrongylus costaricensis Add Parastrongylus costaricensis No Change Chapter 2 No Change Neoplasms (C00-D49) No Change Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80) No Change C79 Secondary malignant neoplasm of other and unspecified sites Delete Excludes2: lymph node metastases (C77.0) No Change C79.1 Secondary malignant neoplasm of bladder -
EFFECTIVE NEBRASKA DEPARTMENT of 01/01/2017 HEALTH and HUMAN SERVICES 173 NAC 1 I TITLE 173 COMMUNICABLE DISEASES CHAPTER 1
EFFECTIVE NEBRASKA DEPARTMENT OF 01/01/2017 HEALTH AND HUMAN SERVICES 173 NAC 1 TITLE 173 COMMUNICABLE DISEASES CHAPTER 1 REPORTING AND CONTROL OF COMMUNICABLE DISEASES TABLE OF CONTENTS SECTION SUBJECT PAGE 1-001 SCOPE AND AUTHORITY 1 1-002 DEFINITIONS 1 1-003 WHO MUST REPORT 2 1-003.01 Healthcare Providers (Physicians and Hospitals) 2 1-003.01A Reporting by PA’s and APRN’s 2 1-003.01B Reporting by Laboratories in lieu of Physicians 3 1-003.01C Reporting by Healthcare Facilities in lieu of Physicians for 3 Healthcare Associated Infections (HAIs) 1-003.02 Laboratories 3 1-003.02A Electronic Ordering of Laboratory Tests 3 1-004 REPORTABLE DISEASES, POISONINGS, AND ORGANISMS: 3 LISTS AND FREQUENCY OF REPORTS 1-004.01 Immediate Reports 4 1-004.01A List of Diseases, Poisonings, and Organisms 4 1-004.01B Clusters, Outbreaks, or Unusual Events, Including Possible 5 Bioterroristic Attacks 1-004.02 Reports Within Seven Days – List of Reportable Diseases, 5 Poisonings, and Organisms 1-004.03 Reporting of Antimicrobial Susceptibility 8 1-004.04 New or Emerging Diseases and Other Syndromes and Exposures – 8 Reporting and Submissions 1-004.04A Criteria 8 1-004.04B Surveillance Mechanism 8 1-004.05 Sexually Transmitted Diseases 9 1-004.06 Healthcare Associated Infections 9 1-005 METHODS OF REPORTING 9 1-005.01 Health Care Providers 9 1-005.01A Immediate Reports of Diseases, Poisonings, and Organisms 9 1-005.01B Immediate Reports of Clusters, Outbreaks, or Unusual Events, 9 Including Possible Bioterroristic Attacks i EFFECTIVE NEBRASKA DEPARTMENT OF -
Connecticut Insurance Coverage for Specialized Formula; New York's “Hannah's Law”
OLR RESEARCH REPORT July 5, 2012 2012-R-0304 CONNECTICUT INSURANCE COVERAGE FOR SPECIALIZED FORMULA; NEW YORK'S “HANNAH'S LAW” By: Janet L. Kaminski Leduc, Senior Legislative Attorney You asked if Connecticut law requires health insurance policies to cover specialized formula used for treating eosinophilic disorder. You also asked for a description of New York’s “Hannah’s Law.” SUMMARY Connecticut insurance law does not explicitly require health insurance policies to cover specialized formulas for treating eosinophilic disorder. However, the law requires specified health insurance policies to cover medically necessary specialized formula for children up to age 12 for treating a disease or condition when the formula is administered under a physician’s direction. Thus, it appears that this would include coverage of specialized formulas for treating eosinophilic disorder. Anyone denied such coverage may appeal to their insurance carrier (internal appeal) or the Insurance Department (external appeal). The explanation of benefits from the carrier describes the appeal process. Anyone with concerns or questions about his or her insurance coverage may contact the Insurance Department’s Consumer Affairs Division at (800) 203-3447 or (860) 297-3900. More information about contacting the department is available at http://www.ct.gov/cid/cwp/view.asp?q=254352. Sandra Norman-Eady, Director Room 5300 Phone (860) 240-8400 Legislative Office Building FAX (860) 240-8881 Connecticut General Assembly Hartford, CT 06106-1591 http://www.cga.ct.gov/olr Office of Legislative Research [email protected] A bill (“Hannah’s Law”) in the New York Assembly would require health insurance policies to cover the cost of enteral formulas for treating eosinophilic esophagitis and related eosinophilic disorders. -
Aow 1920 37 Coronavirus Infodemic
1. Mark your confusion. 2. Show evidence of a close reading. 3. Write a 1+ page reflection. The Coronavirus Infodemic How the coronavirus sparked a tsunami of misinformation. Here's everything you need to know. Source: TheWeek.com, May 17, 2020 What's being said? Social media has been awash in lies, rumors, and distortions about the coronavirus, its origins, and potential cures almost since the pandemic's start. NewsGuard, a private company that rates websites' reliability, has identified 203 websites throughout the world promoting COVID-19 misinformation. Among the most popular COVID-19 myths were "Garlic can cure COVID-19," "A group funded by Bill Gates patented the coronavirus," and "The COVID-19 virus is a man- made bioweapon." The World Health Organization is calling the deluge of misinformation "an infodemic," while Google, Facebook, and Twitter are instituting policies to help slow the spread of lies. CEO Mark Zuckerberg's Facebook fact-checkers have "taken down hundreds of thousands of pieces of misinformation," and slapped warnings on 40 million posts during March alone, the company says. Last week, YouTube removed a video titled "Plandemic" that had been viewed millions of times, featuring discredited microbiologist and anti-vaxxer Judy Mikovits. In the video and a book that reached No. 1 on Amazon, Mikovits contends the coronavirus was created and spread by a conspiracy of wealthy people and scientists such as Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, to bolster vaccine rates and make money. Mikovits has been claiming her career was destroyed by Fauci and other scientists since she falsely reported in a 2009 study, later retracted by the journal that published it, that a retrovirus caused chronic fatigue syndrome. -
Eye Disease 1 Eye Disease
Eye disease 1 Eye disease Eye disease Classification and external resources [1] MeSH D005128 This is a partial list of human eye diseases and disorders. The World Health Organisation publishes a classification of known diseases and injuries called the International Statistical Classification of Diseases and Related Health Problems or ICD-10. This list uses that classification. H00-H59 Diseases of the eye and adnexa H00-H06 Disorders of eyelid, lacrimal system and orbit • (H00.0) Hordeolum ("stye" or "sty") — a bacterial infection of sebaceous glands of eyelashes • (H00.1) Chalazion — a cyst in the eyelid (usually upper eyelid) • (H01.0) Blepharitis — inflammation of eyelids and eyelashes; characterized by white flaky skin near the eyelashes • (H02.0) Entropion and trichiasis • (H02.1) Ectropion • (H02.2) Lagophthalmos • (H02.3) Blepharochalasis • (H02.4) Ptosis • (H02.6) Xanthelasma of eyelid • (H03.0*) Parasitic infestation of eyelid in diseases classified elsewhere • Dermatitis of eyelid due to Demodex species ( B88.0+ ) • Parasitic infestation of eyelid in: • leishmaniasis ( B55.-+ ) • loiasis ( B74.3+ ) • onchocerciasis ( B73+ ) • phthiriasis ( B85.3+ ) • (H03.1*) Involvement of eyelid in other infectious diseases classified elsewhere • Involvement of eyelid in: • herpesviral (herpes simplex) infection ( B00.5+ ) • leprosy ( A30.-+ ) • molluscum contagiosum ( B08.1+ ) • tuberculosis ( A18.4+ ) • yaws ( A66.-+ ) • zoster ( B02.3+ ) • (H03.8*) Involvement of eyelid in other diseases classified elsewhere • Involvement of eyelid in impetigo -
SCR-71 Submitted On: 3/18/2021 10:06:08 PM Testimony for PSM on 3/23/2021 1:10:00 PM
SCR-71 Submitted on: 3/18/2021 10:06:08 PM Testimony for PSM on 3/23/2021 1:10:00 PM Testifier Present at Submitted By Organization Position Hearing Isabel Espiritu Individual Oppose No Comments: Aloha, We the people of Hawaii do not want Resolution SCR71 to pass. We should be able to fly without showing any proof of any medical records. This is medical discrimination, unethical and a direct violation on our constitutional rights. SCR-71 Submitted on: 3/22/2021 4:12:11 AM Testimony for PSM on 3/23/2021 1:10:00 PM Testifier Present at Submitted By Organization Position Hearing Lily Gavri Individual Oppose No Comments: Everything that is going on with Covid as well as the entire medical and pharmaceutical industry is built on the germ theory of disease by Louis Pasteur which proposes that particles in the air are the cause of disease. This has never been proven in accordance with Koche’s postulates which are the principles by which microorganisms are scientifically identified and isolated. They are: 1. The microorganism must be identified in all individuals affected by the disease, but not in healthy individuals. 2. The microorganism can be isolated from the diseased individual and grown in culture. 3. When introduced into a healthy individual, the cultured microorganism should cause disease. 4. The microorganism must then be re-isolated from the experimental host, and found to be identical to the original microorganism. This has never been done with a virus. What they do when trying to identify a virus is they take a healthy cell, starve and poison it and when it dies they claim the leftover particles of the dead cell are newly formed “viruses” “The CDC has NEVER isolated and purified ANY alleged "virus." They simply isolate certain particles that are a natural part of the human body's processes and place that isolated particle into a petri dish wherein they mix it with monkey kidney cells and chemicals and starve the cell whereby it begins to break down. -
European Conference on Rare Diseases
EUROPEAN CONFERENCE ON RARE DISEASES Luxembourg 21-22 June 2005 EUROPEAN CONFERENCE ON RARE DISEASES Copyright 2005 © Eurordis For more information: www.eurordis.org Webcast of the conference and abstracts: www.rare-luxembourg2005.org TABLE OF CONTENT_3 ------------------------------------------------- ACKNOWLEDGEMENTS AND CREDITS A specialised clinic for Rare Diseases : the RD TABLE OF CONTENTS Outpatient’s Clinic (RDOC) in Italy …………… 48 ------------------------------------------------- ------------------------------------------------- 4 / RARE, BUT EXISTING The organisers particularly wish to thank ACKNOWLEDGEMENTS AND CREDITS 4.1 No code, no name, no existence …………… 49 ------------------------------------------------- the following persons/organisations/companies 4.2 Why do we need to code rare diseases? … 50 PROGRAMME COMMITTEE for their role : ------------------------------------------------- Members of the Programme Committee ……… 6 5 / RESEARCH AND CARE Conference Programme …………………………… 7 …… HER ROYAL HIGHNESS THE GRAND DUCHESS OF LUXEMBOURG Key features of the conference …………………… 12 5.1 Research for Rare Diseases in the EU 54 • Participants ……………………………………… 12 5.2 Fighting the fragmentation of research …… 55 A multi-disciplinary approach ………………… 55 THE EUROPEAN COMMISSION Funding of the conference ……………………… 14 Transfer of academic research towards • ------------------------------------------------- industrial development ………………………… 60 THE GOVERNEMENT OF LUXEMBOURG Speakers ……………………………………………… 16 Strengthening cooperation between academia -
Distal Myopathies a Review: Highlights on Distal Myopathies with Rimmed Vacuoles
Review Article Distal myopathies a review: Highlights on distal myopathies with rimmed vacuoles May Christine V. Malicdan, Ikuya Nonaka Department of Neuromuscular Research, National Institutes of Neurosciences, National Center of Neurology and Psychiatry, Tokyo, Japan Distal myopathies are a group of heterogeneous disorders Since the discovery of the gene loci for a number classiÞ ed into one broad category due to the presentation of distal myopathies, several diseases previously of weakness involving the distal skeletal muscles. The categorized as different disorders have now proven to recent years have witnessed increasing efforts to identify be the same or allelic disorders (e.g. distal myopathy the causative genes for distal myopathies. The identiÞ cation with rimmed vacuoles and hereditary inclusion body of few causative genes made the broad classiÞ cation of myopathy, Miyoshi myopathy and limb-girdle muscular these diseases under “distal myopathies” disputable and dystrophy type 2B (LGMD 2B). added some enigma to why distal muscles are preferentially This review will focus on the most commonly affected. Nevertheless, with the clariÞ cation of the molecular known and distinct distal myopathies, using a simple basis of speciÞ c conditions, additional clues have been classification: distal myopathies with known molecular uncovered to understand the mechanism of each condition. defects [Table 1] and distal myopathies with unknown This review will give a synopsis of the common distal causative genes [Table 2]. The identification of the myopathies, presenting salient facts regarding the clinical, genes involved in distal myopathies has broadened pathological, and molecular aspects of each disease. Distal this classification into sub-categories as to the location myopathy with rimmed vacuoles, or Nonaka myopathy, will of encoded proteins: sarcomere (titin, myosin); plasma be discussed in more detail.